We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




PET-CT System Provides Advanced Tumor Detection

By HospiMedica International staff writers
Posted on 03 Nov 2009
New imaging technology combines the abilities of a high-resolution positron emission tomography (PET) system with those of high-quality diagnostic computed tomography (CT) scanner. More...
This unique combination of technologies results in improved image quality reduced scan times and increased patient comfort.

Siemens Healthcare (Erlangen, Germany) reported October 13, 2009, at the annual meeting of the European Association of Nuclear medicine (EANM) in Barcelona, Spain, that leading hospitals in England, France, Germany, and Monaco have shown strong interest and adoption of the Biograph mCT, the world's first molecular CT, to drive advanced diagnostic capabilities and to drive greater workflow efficiencies.

The Biograph mCT has achieved widespread global adoption due to its innovative features and benefits. A uniform 2-mm image resolution throughout the entire field-of-view can considerably improve image quality and offer clinicians increased confidence in diagnosis. The ability for five-minute, whole-body PET scanning, combined with a large bore and short tunnel, offers a more flexible solution for demanding workflows, as well as a more comfortable environment for the patient.

The system is unique in that it can serve as a PET-CT system for molecular imaging, and at the same time, it is powerful enough to serve as a dedicated CT. Among the first to work with the new system is Dr. Andreas Bockisch, director of the Clinic for Nuclear Medicine, University Clinic (Essen, Germany), and president of the German Society for Nuclear Medicine. "Technology and the work environment are important factors in medical imaging diagnostics,” said Dr. Bockisch. "Improvements in image quality immediately increase diagnostic certainty.”

With the Biograph mCT, one examination room serves two modalities. PET and CT scans alike can be performed by one team of operators using only one schedule and. The technology provides functional, anatomic, and molecular information from noninvasive examinations, plus a high level of efficiency. The high definition PET (HD-PET) technology of the new system enables faster scan times, as well as sharper and more precise images. As compared to previous solutions, Biograph mCT is currently the only system that performs routine PET-CT scanning in only five minutes, and combined with a homogeneous 2-mm resolution across the entire field-of-view, it produces high-quality diagnostic images that surpass standard PET images.

The compact design of the Biograph mCT also makes the system more patient-friendly than conventional systems. An oversized 78-cm bore and short tunnel, in combination with an extra-wide and comfortable patient table designed for a capacity of 227 kg, are highly suitable for patients previously considered difficult to examine, such as bariatric or geriatric patients.

Dr. Gerald Antoch, head of the department and assistant director at the Institute for Diagnostic and Interventional Radiology and Neuroradiology at the University Clinic Essen, envisions the combination of PET and high-performance spiral CT opening up completely new possibilities in the area of hybrid oncological and cardiac diagnostics.

"It allows us to apply examination protocols specific to a particular disease in a patient-oriented manner,” said Dr. Antoch. "Some excellent examples of this are PET/CT colonographies for patients suffering from colon cancer or hybrid cardiac imaging for patients with coronary cardiac pathologies.”

Moreover, the TrueV option expands the axial field of view of the PET portion of Biograph mCT by one-third--increasing the performance of the system enormously. When required, the physician is able to individually reduce the dose or scan times, or considerably improve image quality.

The system is also equipped with a CT system that can adjust to a patient's needs and medical requirements. As the first molecular CT scanner, Biograph mCT combines dynamic components, such as movable adaptive dose screening and a scan range of up to two meters. The scanner's high temporal resolution of up to 74 milliseconds, combined with up to 128 slices per rotation, enables display of even the finest anatomic details at reduced motion artifacts. Using the Adaptive Dose Shield, the system avoids unnecessary radiation during all examinations. This ensures that the patient is exposed only to the clinically required dose.

Related Links:

Siemens Healthcare


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.